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Introduction and Objective

Project 2: Pharmacokinetics

Project 3: Behavior and Movement

Passing the 2014 and 2018 Farm Bill Acts
stimulated interest in hemp and its
derivatives. Cannabidiol (CBD) is being
touted as a comprehensive treatment
option for a variety of human and animal
ailments. Currently, CBD products lack
fundamental research pertinent to
regulation of product quality and dosing
recommendations, particularly in equines
where it is frequently being used for
behavior modification. Three studies were
designed to better understand the effects of
CBD supplementation in horses.

Methods
 6 horses: single dosage 50 mg PEL
 6 horses: single dosage 100 mg PEL
 6 horses: single dosage 250 mg PEL
 Blood collected pre-treatment and
0.5, 1, 2, 4 and 12 hr post-treatment

Methods
 12 horses: 100 mg PEL daily for 12 wk
 12 horses: 0 mg PEL
 Novel object reaction test
 Flexion and movement evaluations
 Blood pre-treatment and every 2 wk for
12 wk of supplementation

Project 1: Pilot

Results
 250 mg dose consistently detected
at 1 ng/ml (n=5/6)
 Peak concentration and clearance
times similar to other species
 Changes in liver enzymes, but values
within normal ranges

Methods
 Horse 1: single 50 mg dosage PEL
 Horse 2: single 50 mg dosage OIL
 Blood collected 1 and 2 hr post treatment

Project currently in progress.

Figure 3. Novel object reaction test in horses
before CBD supplementation

Results
 CBD not detected at standard lower limit
concentration of 1 ng/ml
Figure 2. Pharmacokinetics of a single 250
 Detected at 0.05 ng/ml

Implications and Further Research
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Figure 1. Serum CBD concentration (ng/ml) in
horses fed a single 50 mg treatment of pellets
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Current dosage recommendations for
horses (25-50 mg/d) based on small
animal dosage and may not be
appropriate on body weight basis
Supplementation at lower doses may
be needed for several weeks before
effects seen on behavior in horses,
possible accumulation in tissues?
Higher doses may have more
immediate effect on painful conditions
(neuropathy, arthritis?)
Liver enzyme changes needs further
evaluation

